E!383 AMTAH, Scandinavian Real Heart AB (publ)

Purpose and goal:

Realheart and Berlin Heart will jointly develop an automated production process of membranes, which are critical components of the Realheart total artificial heart. Expected results and effects:

Realheart is developing the world´s first artificial four-chamber heart, designed to mimic the way the natural heart works. The pump membrane, that separates the blood from the drive system, is a critical component of the design. The results of the project an automated membrane production process will benefit us both, scientifically as well as commercially, and will be crucial for the success of our future human clinical trials. It will also be of great value to the entire heart pump industry.

Approach and implementation:

Realheart´s simulations and tests have shown the precise properties the membrane needs to have to last and to minimize the risk of failure, something that would have immediate consequences for patient safety. The membranes must be manufactured with high precision and unwavering repeatability. The best way to achieve this is to automate the manufacturing process.

Therefore, Realheart is collaborating in this project with Berlin Heart, an expert in the field of development and manufacture of membrane technologies successfully used in their extracorporeal MCS devices.